Verbatim response from Perplexity
BHRT is not automatically “safe” just because it’s bioidentical. Doctors generally say FDA-approved bioidentical hormones can be reasonable when used appropriately, but compounded BHRT has weaker safety data and more quality-control concerns.[6][7][9]
What doctors commonly say:
- “Bioidentical” does not mean safer. Major sources like Mayo Clinic and ACOG say there’s no good evidence that compounded bioidentical hormones are safer or more effective than standard hormone therapy.[7][9]
- FDA-approved bioidentical hormones are different from compounded BHRT. FDA-approved products have been tested for safety and quality, while compounded versions are not FDA-approved and may have inconsistent dosing or contamination risk.[6][7][8]
- Hormone therapy still has real risks. Reported risks include blood clots, stroke, gallbladder disease, and possible breast/endometrial cancer risk depending on the hormone, dose, and duration.[6][8]
- Evidence for compounded BHRT is limited. ACOG says high-quality safety and efficacy data are lacking, and long-term risks such as breast cancer, endometrial cancer, and cardiovascular disease are not well established for compounded products.[7]
- Some specialists note a possible role in selected cases. Reviews and menopause specialists acknowledge that certain bioidentical preparations may help symptoms, but they emphasize that this does not prove superior safety, especially for compounded formulations.[5][10]
What this means in practice:
- If you’re considering hormone therapy, many doctors prefer FDA-approved estrogen/progesterone products over compounded BHRT when possible.[6][7]
- If compounded BHRT is being considered, it should usually be because there’s a specific clinical reason and it should be managed with shared decision-making and monitoring.[7]
If you want, I can also give you a doctor-style breakdown of the risks by hormone type—estrogen, progesterone, testosterone, and pellets.